What was Gemina Laboratories Ltd.’s price range in the past 12 months?
Gemina Laboratories Ltd. lowest stock price was C$0.20 and its highest was C$0.65 in the past 12 months.
What is Gemina Laboratories Ltd.’s market cap?
Currently, no data Available
When is Gemina Laboratories Ltd.’s upcoming earnings report date?
Gemina Laboratories Ltd.’s upcoming earnings report date is May 31, 2024 which is in 13 days.
How were Gemina Laboratories Ltd.’s earnings last quarter?
Gemina Laboratories Ltd. released its earnings results on Dec 29, 2023. The company reported -C$0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.016.
Gemina Laboratories Ltd. does not currently pay dividends.
What is Gemina Laboratories Ltd.’s EPS estimate?
Gemina Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gemina Laboratories Ltd. have?
Gemina Laboratories Ltd. has 73,325,874 shares outstanding.
What happened to Gemina Laboratories Ltd.’s price movement after its last earnings report?
Gemina Laboratories Ltd. reported an EPS of -C$0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Gemina Laboratories Ltd.?
Currently, no hedge funds are holding shares in TSE:GLAB
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. It endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers (the Gemina Surface Chemistry).